Samarium 153 in metastatic bone pain: palliative to curative benefits?

被引:0
|
作者
Ben Ghachem, T. [1 ]
Mhiri, A. [1 ]
Slim, I. [1 ]
Bahloul, A. [1 ]
Charfi, H. [1 ]
Yeddes, I. [1 ]
Elbez, I. [1 ]
Meddeb, I. [1 ]
Ben Slimene, M. F. [1 ]
机构
[1] El Manar II Univ, Dept Nucl Med, Salah Azaiez Inst, Tunis, Tunisia
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S504 / S505
页数:2
相关论文
共 50 条
  • [21] Prognostic significance of serum angiogenin and Her-2 in 153-Samarium pain palliation therapy of bone metastatic prostate cancer
    Siampanopoulou, M.
    Ordoulidis, S. El-Mantani
    Iakovou, I.
    Dimasis, N.
    Sioundas, A.
    Gotzamani-Psarrakou, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S502 - S503
  • [22] Palliative Treatment of Bone Metastases with Sm-153 EDTMP at Pain Onset
    D'Antuono, F.
    Nardelli, A.
    Gallicchio, R.
    Giacomobono, S.
    Venetucci, A.
    Pellegrino, T.
    Leggiadro, F.
    D'Errico, N.
    Gattozzi, D.
    Mainenti, P.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S188 - S189
  • [23] DOSIMETRY AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN DUE TO SKELETAL METASTASES
    BAYOUTH, JE
    MACEY, DJ
    KASI, LP
    FOSSELLA, FV
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (01) : 63 - 69
  • [24] Efficacy and safety of systemic samarium 153 therapy in metastatic breast cancer patients with widespread bone metastases
    Lacko, A
    Pajak, K
    Kolodziejczyk, A
    Zebrowski, J
    Garncarek, A
    Filipczyk-Cisarz, E
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S259 - S259
  • [25] Evalution of Samarium153-lexidronam in the palliative treatment of prostate adenocarcinoma
    El Ajmi, W.
    Zaabar, L.
    Mahjoub, Y.
    Sellem, A.
    Hammami, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S576 - S576
  • [26] Samarium-153 lexidronam for painful bone metastases
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1997, 39 (1008): : 83 - 84
  • [27] Evaluation of treatment efficacy of metastatic bone pain with 153Sm-EDTMP
    Beiki, D.
    Fallahi, B.
    Keyvan, A.
    Haddad, P.
    Fard-Esfahani, A.
    Hashemi, F. Ammozegar
    Ardekani, A. Emami
    Saghari, M.
    Eftekhari, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S433 - S433
  • [28] Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: A double-blind placebo-controlled clinical trial
    Serafini, AN
    Houston, SJ
    Resche, I
    Quick, DP
    Grund, FM
    Ell, PJ
    Bertrand, A
    Ahmann, FR
    Orihuela, E
    Reid, RH
    Lerski, RA
    Collier, BD
    McKillop, JH
    Purnell, GL
    Pecking, AP
    Thomas, FD
    Harrison, KA
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1574 - 1581
  • [29] Background, Reasons and Benefits Using the Vienna Protocol for the Treatment of Painful Bone Recurrences with 153Samarium-EDTMP
    Sinzinger, Helmut
    Weiss, Konrad
    Hiltunen, Jukka
    ANTICANCER RESEARCH, 2009, 29 (08) : 3393 - 3395
  • [30] BACKGROUND, REASONS AND BENEFITS USING THE VIENNA PROTOCOL FOR THE TREATMENT OF PAINFUL BONE RECURRENCES WITH 153SAMARIUM-EDTMP
    Sinzinger, H.
    Granegger, S.
    Weiss, K.
    Hiltunen, J.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3488 - 3488